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In recent years several countries have introduced reforms to user fees; a growing 
number of countries are also introducing basic health care free at the point of use. In 
many cases, the focus has been on making health care more accessible for priority 
groups, particularly pregnant women and young children.  
 
However, despite the high interest in user fee removal, there are many information 
gaps on the current status of user fees in low-income countries, particularly for those 
interested in carrying out international comparisons. This paper presents a useful 
snapshot of some patterns in this changing area of health financing from 49 countries 
in Africa and Asia. 
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1. Introduction 
 
Recent UN and other international initiatives have highlighted the importance of addressing the 
financial barriers to accessing health care, including user fees, which represent one of main barriers 
for poor people (Yates 2010).1 Several countries have reduced or removed user fees, and more are 
planning to do so. However, user fee removal can have many implications for the wider health system, 
and is likely to require other policy and management reforms, to ensure for example that health 
facilities are prepared for increased demand for services and supplies. 
 
Despite the high interest in user fee removal, there has been limited synthesis of current payment 
arrangements at point of use in low income countries. This paper is based on work commissioned by 
DFID in 2009 to analyse current practices in relation to user fees in low income countries to help 
inform decision-making and strategy development at both global and country levels. It draws upon a 
wider study to develop a health systems typology conducted by McPake et al (2009), which included a 
survey of key informants from a large number of low-income countries. 
 
 
Key findings 
 
 User fees are extremely prevalent – only six out of the 50 health systems included here (high 
mortality countries in Africa and Asia) do not have some form of user fees in the public sector. 
There is no particular economic pattern to these six countries, though a large number are recently 
post-conflict.  
 Of those with fees, all bar two offer a range of exemptions, mainly focused on communicable 
diseases but also vulnerable groups such as the very poor. On the whole these are seen as only 
‘somewhat effective’.  
 Estimates for income raised from user fees as a proportion of public resources for health care vary, 
but the most common estimate is 0-9%.  
 A third of respondents thought that informal payments were ‘common but low’ – this was the most 
common opinion. There is no clear pattern of relationship between reported informal payments and 
reported levels of user fees, though five of the six countries with no fees reported informal 
payments to be rare.  
 In terms of overall health financing, out-of-pocket payments are the largest single source for the 
group as a whole, followed by tax, aid and then pooled private finance (only 9% of the total).  
 There have been considerable reform efforts in the past few years in relation to user fees – more 
than half the countries had introduced some kind of national changes, the most common of which 
has been to remove fees for deliveries (sometimes all deliveries, sometimes focused on 
emergency obstetric care) and sometimes also for children. There has also been a growing number 
of countries introducing free basic health care (by level or service type). 
 
 
2. Background: the changing role of user fees 
 
User fees for health care have been a feature of the health financing mix in most countries, but 
increased in importance and frequency, especially in low-income countries, from the 1980s onwards in 
response to financing gaps for public health provision. There has been considerable controversy about 
their role, with advocates putting the case for user fees based on the need for additional resources, 
investment in quality services and reduction of frivolous demand (Litvack and Bodart 1993; World 
Bank 1987), and opponents providing evidence of negative impacts on utilisation and equity, as well 
as disappointing performance in relation to revenue collection (Gilson, Russell, and Buse 1995; Witter 
2005). 
 
The emerging consensus view emphasises the need for health financing mechanisms which increase 
risk pooling, move towards the goal of universal coverage and reduce out-of-pocket payments by 
users (Arhin-Tenkorang 2001). In this context, much of the debate has moved towards the ways in 
                                                 
1 For example, one of the five pillars of the Consensus for Maternal, Newborn and Child Health, 
agreed in 2009, includes: ‘Removing barriers to access, with services for women and children being 
free at the point of use where countries choose’ (see www.pmnch.org for more details). 
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which user fees can be rolled back while avoiding further shocks to fragile health systems (Save the 
Children 2008). While user fees are recognised by most as the ‘last resort’ method for raising funds for 
health services, they do provide flexible resources at facility level. If these are lost but not replaced by 
resources of adequate quantity and quality (e.g timely and flexible), then service quality and 
effectiveness will deteriorate (Gilson and McIntyre 2005; James et al. 2006; Pearson 2004).  
 
This area of health financing is very dynamic, with many countries introducing reforms to user fees in 
recent years. The aims of these reforms have typically been to reduce the overall burden of direct 
payments for users, and/or to target benefits to priority user groups and services. In many cases, with 
an eye to slow progress towards the Millennium Development Goals, the focus has been on pregnant 
women and young children (Yates 2009). User fee reduction or removal is one such approach. Many 
of these policies are still in their early stages and a body of evidence based on thorough evaluations 
has not yet emerged (Richard, Witter and De Brouwere 2008; Witter 2009). 
 
In addition, there remain many information gaps on the current status of user fees in low-income 
countries, particularly for those interested in carrying out international comparisons. Which countries 
charge user fees for health care? What level of fees do they charge? What sort of exemptions do they 
offer? Are these exemptions effective? How do the official fees interact with informal payments by 
users? These are all questions of great practical importance as development partners and researchers 
work to support health financing reforms in these health systems. There is no easy source of answers 
at present. 
 
In 2008, a survey of key informants from a large number of low-income countries was conducted as 
part of an exercise to develop a health system typology (McPake et al. 2009). The survey focused on 
a wide variety of health system variables, identified through literature and discussion; a subset was 
concerned with user fee policies. In this paper, the responses to the user fee questions are explored in 
order to provide some empirical answers on the scale and scope of user fees today in low income 
countries. This information is supplemented with some background data from WHO, which allows us 
to set the policies in an overall health financing context. 
 
3. Research methods 
 
Selection of countries 
The original survey covered 41 high mortality countries2 and five Indian states. Data were added for 
the DFID Public Service Agreement (PSA) countries not covered in the survey (using external key 
informants and published literature). Of the resulting 49 countries 38 are in Africa and 11 in Asia.  
 
Selection of key informants 
To identify appropriately knowledgeable respondents, personal contacts of the original research team 
were approached and ‘snowball sampling’ was used to further extend the list of potential experts in 
each country (McPake et al. 2009). The aim was to approach one expert from government, one from 
an NGO, and one from a donor agency in each country. A number of difficulties were encountered in 
securing the targeted sample size; in the end 92 respondents were interviewed, including 33 from 11 
countries where the full three experts had been successfully interviewed. Many more countries (21) 
had two respondents, and in 13 countries they only managed to interview one expert. 
 
The survey 
The overall survey contained questions on a wide range of features of the health system that could be 
identified with performance and which might affect maternal, neonatal and child health outcomes. This 
included variables related to the provision of services, stewardship, financing and integration of 
services. These were identified through literature reviews and focus group discussions with health 
systems experts.  
 
The few questions on user fees asked whether there were user fees in the health system, and then 
whether there were any exemptions. Respondents were asked about the categories of services and 
users for which exemptions were offered. They were also asked whether the exemptions were 
effective (with three possible answers); what proportion of public resources were raised from user fees 
(with five bands of answers); what the situation was in the country in relation to informal payments 
(with four possible responses) and whether public facilities charged for malaria diagnostics. 
                                                 
2 Defined as those with an under-five mortality rate of 90 per thousand or above in 2005. 
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The survey was administered by telephone, though copies of the questions were sent in advance so 
that informants could prepare themselves. Interviews took 36 minutes on average. Answers were 
entered into the statistics software, SPSS. 
 
Sources for background information 
In order to set the user fee information in a wider health financing context, we supplemented the 
survey data with background information on health financing, taken from the WHO Statistical 
Information Service (WHOSIS) in September 2009 (with data mostly drawn from the year 2006), and 
with information on recent reforms of user fee regimes, based on personal knowledge, available 
literature and discussion with specific experts. 
 
Study limitations 
Researchers from the original study noted some limitations linked to the key informants – namely, that 
the choice of key informants was based on reputation, rather than any test of expertise; that the range 
of questions was broad and individuals might not be expected to be able to respond accurately on all 
areas; and that responses might have been biased towards ‘official’ answers rather than more realistic 
assessments.  
 
In addition, the data obtained had problems of :a) incompleteness (particularly for some areas, such 
as the private sector); b) disagreement between respondents from the same country; and c) an 
unbalanced design, in that the number of respondents per country varied, ranging from one to four. 
Using tests for concurrence between different respondents from the same country, the study authors 
retained the answers to questions about user fees, exemptions and malaria diagnostic charging, but 
rejected the responses on informal payments. 
 
The supplementary information also suffers from lack of completeness, particularly in terms of the user 
fee reforms. These are based on published literature and the author’s knowledge. There may 
therefore be other policy reforms which have been omitted. 
 
Reliability and completeness of information 
Most of the information (other than the health financing breakdown) is taken from key informants, 
personal knowledge and literature. It is therefore not guaranteed to be accurate. However, where 
responses have been checked against known contexts, they have been found to be accurate for most 
of the questions.   
 
The two questions which elicited the greatest variety of response were those on proportion of public 
revenue raised by user fees and on informal charges. This is perhaps easy to understand, as in many 
contexts the extent of informal charging is not publicly disclosed, while the proportion of revenue is 
quite a technical question. 
 
In addition, the list of countries is not comprehensive, focusing as it does on high-mortality countries in 
Africa and Asia, with the addition of PSA countries in those regions. 
 
Overall, the survey and additional material reveals a useful snapshot of some patterns in this changing 
area of health financing, which require further investigation. Table 2 in the Annex shows the country 
findings on fees and health financing. 
 
4. Overview of findings 
 
Most countries – 88% of those reviewed – continue to apply user fees. Those that do not span 
a variety of income levels. 
The first striking finding from the survey is how few of the countries in this group report that they do not 
have user fees. Of the 50 countries included (if we count North and South Sudan as two different 
health systems), only six do not have any form of user fees in the public sector3. These are: Angola, 
Liberia, Malawi, South Sudan, Uganda and (sole in Asia) Timor-Leste. Two countries (Myanmar and 
Gambia) are undecided about whether they have fees or not. All others apply some form of user fee. 
                                                 
3 Some countries, such as Sierra Leone, have introduced new free service policies since the survey 
was undertaken.  
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On the specific issue of malaria tests, roughly half of the countries report charging for these in their 
public facilities. 
 
The countries which do not have user fees are not linked by income level. Looking at GDP per capita 
(in Purchasing Power Parity terms), they range from two of the wealthiest in the group (East Timor, at 
$5,100 per capita and Angola at $3, 890 per capita) to one close to average (South Sudan, at $1,780, 
at least for north and south combined), to two below average (Uganda at $880 and Malawi at $690), 
as well as the poorest of the whole set (Liberia, at $260). Most have recently emerged from conflict, 
but not all (Uganda and Malawi). 
 
Virtually all of the countries that apply user fees try to exempt at least some users. The 
effectiveness of this strategy is limited.  
Of those with user fees, all bar two (Central African Republic and Mauritania) offer exemptions of 
some kind. A wide variety of categories are mentioned as exempt, though informants often disagree 
on which ones. The most commonly cited categories are the poor and TB patients (54% of 
respondents say ‘yes’ to these categories), followed by HIV (53%), immunisation (42%), leprosy, 
maternal conditions and children (35% each), malaria, the elderly and orphans and vulnerable children 
(17% each), ex-servicemen (10%), the disabled and civil servants (6.5%), the unemployed (3%) and 
adolescents (1%).  
 
The overall focus of exemptions, then, appears to be on infectious disease control, with the addition of 
some priority social groups. Some of the responses are surprising. For example, it seems likely that a 
higher proportion of countries offer free immunisation services than the reported 42%. This may reflect 
low awareness on the part of key informants, but that, in itself, would be a matter for concern.  
 
Of course, it is well known that exemptions can be theoretical, with poor realisation when patients 
arrive for services – hence the question of assessing their effectiveness. Overall, the most common 
verdict is ‘somewhat effective’ – neither completely ineffectual nor fully effective, which accords with 
the literature (Bitran and Giedion 2003). Only four countries report a unanimous verdict of ‘very 
effective’ – Burundi, Gambia, Niger and South Africa. For some, there is not enough evidence yet 
(Nepal), while others emphasise that the system works for official fees but not informal barriers 
(Indonesia) and unofficial charges (Bangladesh). 
 
Reported revenue from user fees tends to be relatively low – but there are exceptions. 
The estimates for proportion of public resources raised from user fees vary across informants. Most 
fall in the lowest band, but a significant clump at higher ranges too. The most common response is 0-
9% (43% of respondents – 83% overall responded to this question), followed by 10-19% and 50%+ 
(12%), 30-49% (9%) and 20 – 29% (6.5%).  
 
Informal payments are most commonly described as routine but low. There is no clear pattern 
of linkage between user fees and informal payments. 
Of the 95% of survey respondents to the informal payments question, 33% reported that ‘they are 
common or routine but are levied at low rates that are of limited significance for access to services’. 
26% said that ‘they are sometimes levied but are confined to a few areas or a few service types’; 21% 
reported that ‘they are very rare - patients normally receive services free or pay only the formal 
charge’; 15% reported that ‘they are common or routine and levied at high rates with considerable 
significance for access to services’. 
 
There is no clear pattern between the revenue raised from user fees and the pattern of responses on 
informal payments. For example, where people report informal payments to be ‘rare’, they include 
contexts with no user fees (such as Timor Leste) as well as those with high proportions raised through 
user fees (e.g. Ethiopia). On the other hand, of the six countries with no user fees, all report informal 
payments to be rare (with the exception of Uganda, where they are said to be ‘common but low’). 
 
A range of health financing approaches is in place – but heavy reliance on out-of-pocket 
expenditure is a common feature (just under 50% of the total for the group as a whole).   
All health systems have a mix of financing approaches, but the dominant health financing mechanism 
(taking into account all sectors, public and private) is out-of-pocket payments, which accounts for 49% 
of health finance overall for the group, followed by public (domestic) funding (24%), external aid 
(21%), and finally private risk pooled funding (9%).  
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It is hard to link the health financing patterns with user fee reforms, given that the health financing data 
is from 2006 and many of the reforms have taken place since that date. Out-of-pocket expenditure in 
public sector facilities is also not distinguishable in the total, which often reflects a heavy usage of 
private facilities (and is also averaged across all socio-economic groups). 
 
The user fee picture is changing rapidly – more than half of the countries have modified user 
fee policies in recent years.  
More than half of the countries in this selection (28 out of 50) have, in recent years, introduced reforms 
to their user fee regimes. In many cases (see Table 1 and Table 3 in the Annex), the focus has been 
on priority groups, particularly pregnant women and young children. There is a clear regional focus for 
this in West Africa, but the approach extends beyond the region. Of the 28 countries, exactly half 
focus on delivery care (either exclusively or together with curative services for young children).  
 
 
Table 1. Recent reforms to user fee regimes in the selected countries 
 
Type of reforms to user fee regime Countries Number 
Fee exemption for priority groups (delivery 
care; under-fives; in Senegal also for elderly)
Senegal, Ghana, Mali, Niger, Benin, Burkina 
Faso, Burundi, Kenya, Madagascar, North 
Sudan, Nepal, Sierra Leone 
12 
Making all basic health care free (either 
defined by health service level or by a 
package of care) 
Nepal, Zambia, South Africa, Lesotho, 
Liberia 
5 
Addressing financial barriers via social 
health insurance and community health 
insurance 
Tanzania, Kenya, Rwanda, Ghana 4 
Insurance programmes targeted 
at/subsidised for the poor 
Indonesia, China, Vietnam 3 
All care in the public sector free Uganda, South Sudan 2 
Vouchers for demand-side costs of deliveries Bangladesh, Cameroon 2 
Area-based exemptions Afghanistan 1 
National programmes free (and demand-side 
incentives for priority areas such deliveries) 
India (and Nepal for deliveries) 1 
Health equity funds Cambodia 1 
 
 
5. Conclusions 
 
This dataset is based largely on interviews; therefore it cannot be presented as entirely reliable. 
Moreover, there are disagreements between respondents, even from the same countries, on a 
number of the variables. However, there is sufficient evidence to suggest some broad patterns, which 
are interesting for policy-makers and researchers, particularly given the lack of comparative 
information on some of these topics. 
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Annex 
 
Findings by country  
 
Table 2 presents the findings by country. Column 1 relates to the question of whether official user fees 
were in place in the health sector. There was very rarely any disagreement between respondents on 
this, but where there was, this is indicated. 
 
Column 2 reports on official exemptions where these were in place (clearly, countries with no user 
fees will not offer exemptions). Respondents were requested to report policies in relation to a range of 
specified services but were asked to comment on practices in relation to other services. Where there 
is only one respondent, the categories are taken from their response. Where there are two or three, at 
least two positive responses to a category are needed for it to be listed here. Column 3 reflects 
respondents’ views on whether exemptions worked or not.  
 
Column 4 gives estimated proportion of public revenue for health which comes from official fees. 
These estimates varied considerably in some cases. Answers are given as a range. If one respondent 
reported ‘0-9%’ and another ‘50%+’, then the answer here would be given as ‘0-50%+’.  
 
The same approach is taken for informal charges in column 5 – the range of answers is reflected in 
this column. While for some countries there is consensus amongst respondents, for others there was 
a wide divergence.  
 
For malaria diagnostics, the answer is simply yes (they are charged), or no, or unclear if there is 
disagreement between respondents. 
 
Columns 6 to 9 present the overall sources of health financing in country (covering both public and 
private sectors). These are clearly of interest to see if they are linked to responses on user fees and 
informal payments. The data is derived from WHOSIS. Public funds are divided into public from 
domestic resources (taxes of various kinds) and public from external development partners. Private 
expenditure is broken into out-of-pocket payments and private expenditure which passes through 
some form of risk-sharing mechanism. Out-of-pocket payments will link to user fees, of course, but are 
broader, as they include a wider range of costs and also payments made to private and informal 
practitioners of various types. 
 
Column 9 presents information on any recent changes which have been introduced to user fees. This 
is drawn from literature and from the author’s personal knowledge. 
 
Finally, column 10 indicates the number of respondents per country on the survey. Where an outside 
expert or documents were consulted (for the eight PSA countries which fell outside of the survey 
group), this is indicated here. The range of respondents (for all countries bar India) is 1 - 4. For India, 
the five states have been amalgamated, bringing the total to 9. 
 
Rows highlighted with a box indicate DFID PSA countries (at the time of the research). Where no 
information was available to answer a specific question for these countries, the box was left blank. 
Table 2. Findings on fees and health financing for selected countries 
 
Sources of health financing (overall, public and private sectors) 
Country 
Official user 
fees? Exemptions 
Are 
exemptions 
effective? 
% of 
public 
revenues 
raised 
from 
user fees Informal charges 
Malaria 
diagnostics 
charged in 
public 
facilities? 
Out of 
Pocket 
Public 
(domestic) 
Aid Private  
(risk pooled) 
New policies 
on user fees 
recently? 
N. of 
informants 
AFRICA 
Angola Officially not Not applicable Not applicable 0-9% Rare No  13 80 7 0  3 
Benin Yes 
Disagreement 
– one 
respondent 
reports for 
poor and 
children, TB, 
HIV, 
immunisation Very 50%+ Common but low Yes 47 40 13 0
Free caesarean 
policy 
introduced 2009 2 
Burkina 
Faso Yes 
Yes - poor, 
maternal, 
children, TB, 
leprosy, 
immunisation, 
HIV Somewhat 50+ Sometimes but limited Yes 39 24 33 4
Experimenting 
with free or 
highly 
subsidised 
delivery 
services since 
2006 1 
Burundi Yes 
Yes - maternal 
conditions and 
children, TB, 
leprosy, 
immunisation, 
HIV Very 30-50% 
Sometimes/common but 
low Yes 75 11 14 0
Free care for 
pregnant 
women and 
under-fives 
since 2006 2 
Cameroon Yes 
Yes - TB, 
leprosy, 
immunisation, 
HIV Somewhat 50+ Common - low to high Yes 68 21 7 4
Some trials of 
demand-side 
subsidies, e.g. 
vouchers for 
deliveries, but 
not national in 
scale 2 
Central 
African 
Republic Yes No N/A 10-19% Common but low Yes 61 14 22 3  1 
Chad Yes 
Unclear - 
possibly for 
maternal, 
children, TB, 
leprosy, HIV, 
malaria 
Not at 
all/somewhat 0-19% Common but low Yes 62 12 24 2  3 
 Sources of health financing (overall, public and private sectors) 
Country 
Official user 
fees? Exemptions 
Are 
exemptions 
effective? 
% of 
public 
revenues 
raised 
from 
user fees Informal charges 
Malaria 
diagnostics 
charged in 
public 
facilities? 
Out of 
Pocket 
Public 
(domestic) 
Aid New policies Private  
(risk pooled) on user fees N. of 
recently? informants 
Congo Yes 
Yes - poor, 
TB, malaria, 
HIV Somewhat 0-29% Sometimes but limited Yes 59 37 4 0
Free malaria 
treatment for 
children and 
pregnant 
women since 
2008 3 
Cote d'Ivoire Yes 
Yes - disabled 
and possibly 
some other 
categories Somewhat 0-50%+ Rare/common but low Unclear 68 15 8 9  2 
Democratic 
Republic of 
the Congo Yes 
Yes - poor, 
TB, leprosy, 
HIV (but 
everyone pays 
something) 
Not at 
all/somewhat 0-50%+ Rare/common but low Yes 63 8 29 0
Some free basic 
care provided 
by NGOs, but 
limited 
coverage 3 
Equatorial 
Guinea Yes 
Yes - poor, 
TB, HIV Somewhat 0-19% Sometimes but limited Unclear 16 73 5 6  2 
Ethiopia Yes 
Yes - 
maternal, 
children, TB, 
leprosy, 
immunisation 
Somewhat 
(mixed for 
maternal 
health)/very 0-49% Rare Unclear 32 18 43 8   2 
Gambia 
Disagreement 
-  two say yes 
and two no 
Yes - mothers, 
children, TB, 
immunisation Very 0-9% Sometimes but limited No 29 18 40 12  4 
Ghana Yes 
Yes - poor, 
elderly, 
maternal, 
children, TB, 
leprosy, 
immunisation 
Somewhat/ 
very 0-29% 
Sometimes/common but 
low Yes 50 14 22 13
In new Social 
Health 
Insurance, 
pregnant 
women get free 
cards since 
2008; also 
some indigents, 
elderly, children 
of members 3 
Guinea Yes Yes - HIV Somewhat  30-50%+ Common - low to high Yes 87 1 12 0  2 
Guinea-
Bissau Yes 
Yes – TB, 
leprosy, HIV Somewhat 0-9% 
Sometimes/common and 
high Varies 45 -7 31 31  2 
 
 Sources of health financing (overall, public and private sectors) 
Country 
Official user 
fees? Exemptions 
Are 
exemptions 
effective? 
% of 
public 
revenues 
raised 
from 
user fees Informal charges 
Malaria 
diagnostics 
charged in 
public 
facilities? 
Out of 
Pocket 
Public 
(domestic) 
Aid New policies Private  
(risk pooled) on user fees N. of 
recently? informants 
Kenya Yes 
Yes - poor, 
unemployed, 
elderly, 
orphans, 
maternal, 
children, TB, 
leprosy, 
immunisation, 
HIV Somewhat 0-9% Common but low Yes 41 33 15 10
Experimentation 
with different 
systems of 
exemption, 
subsidy, risk 
pooling, 
insurance in 
recent years; 
deliveries 
exempt since 
2007 1 
Lesotho Yes     3%     26 47 15 12
Removal of fees 
for OPD in 2008 
and some 
streamlining of 
other fees 
Document 
review 
Liberia No N/A N/A 0-9% Rare No 36 22 42 0
User fees 
suspended for 
basic package 
of health care 
since 2006 1 
Madagascar Yes 
Yes - poor, 
civil servants, 
TB, leprosy, 
immunisation, 
HIV Somewhat 30-49% Common but low No 19 13 50 18
User fees lifted 
on emergency 
post-conflict 
basis, then 
reintroduced. 
Free deliveries 
since 2008 1 
Malawi No N/A N/A N/A Rare No 9 29 43 19   3 
Mali Yes 
Yes - poor, 
TB, leprosy, 
HIV Somewhat 10-29% Sometimes but limited No 48 33 18 0
Free 
caesareans 
since 2005 1 
Mauritania Yes No N/A 50%+ Common but low Yes 31 51 18 0  1 
Mozambique Yes 
Yes - poor, 
orphans, 
maternal, 
children, TB, 
immunisation, 
HIV Somewhat/very 0-19% 
Sometimes but 
limited/common but low No 12 13 57 18   2 
 
 Sources of health financing (overall, public and private sectors) 
Country 
Official user 
fees? Exemptions 
Are 
exemptions 
effective? 
% of 
public 
revenues 
raised 
from 
user fees Informal charges 
Malaria 
diagnostics 
charged in 
public 
facilities? 
Out of 
Pocket 
Public 
(domestic) 
Aid New policies Private  
(risk pooled) on user fees N. of 
recently? informants 
Niger Yes 
Yes - poor, 
children, civil 
servants, TB, 
HIV Very 0-9% Rare Yes 40 26 26 7
Free 
caesareans 
(2006) and care 
of under-fives 
(2007) 1 
Nigeria Yes 
Yes - 
maternal, 
leprosy, HIV Somewhat 0-19%
Sometimes/common but 
low Yes 63 24 6 7
Addressed via 
extension of 
CHI and 
subsidies for 
membership, as 
well as supply 
side policies 2 
Rwanda Yes 
Yes - poor, 
orphans, ex-
servicemen, 
HIV, genocide 
survivors Somewhat 0-50%+ Rare Yes 23 25 39 14  2 
Sao Tome 
and Principe Yes Yes - children 
Not at 
all/somewhat 0-29% Common but low Unclear 15 42 43 0  2 
Senegal Yes 
Yes - elderly, 
maternal, TB, 
immunisation, 
malaria, HIV Somewhat 20-29% Sometimes but limited Yes 62 18 14 7
Recent 
introduction of 
exemptions for 
delivery care 
(2006) and 
elderly 1 
Sierra Leone Yes 
Yes - poor, 
maternal, 
children 
Not at 
all/somewhat 0-49%
Common but 
low/common and high Yes 51 4 45 0
Free care 
package for 
mothers + 
under-5s 
planned for 
April 2010 3 
Somalia Yes 
Yes - poor, 
TB, HIV 
(both); elderly, 
mentally 
handicapped, 
all preventive 
care 
(Somaliland); 
children, ex-
servicemen, 
Somewhat/not 
at all 0-49% Rare/common and high Unclear 55 35 9 0  3 
 
 Sources of health financing (overall, public and private sectors) 
Country 
Official user 
fees? Exemptions 
Are 
exemptions 
effective? 
% of 
public 
revenues 
raised 
from 
user fees Informal charges 
Malaria 
diagnostics 
charged in 
public 
facilities? 
Out of 
Pocket 
Public 
(domestic) 
Aid New policies Private  
(risk pooled) on user fees N. of 
recently? informants 
leprosy, 
immunisation 
(Somalia) 
South Africa Yes 
Yes - all PHC 
has been free 
since mid-
1990s Very 0-9% Rare/sometimes  10 41 1 48
Free public 
PHC since 
1990s 
External 
expert 
Sudan 
Yes (North); 
No (South) 
Yes - poor, 
maternal, 
children, TB, 
immunisation 
(North Sudan) 
Somewhat 
(North) 
10-29% 
(North) 
Sometimes/common but 
low (North); Rare (South) Yes (both) 62 31 6 1
Free care for 
under-5s and 
caesareans 
introduced in 
north in 2008; 
South recently 
removed user 
fees 3 
Togo Yes 
Not really 
respected - 
should be for 
poor, HIV, 
indigenous 
Not at 
all/somewhat 30-49% Common and high Yes 61 13 15 11  3 
Uganda No N/A N/A 0-9% Common but low No 38 -2 29 35
Free care in 
public sector 
since 2001 2 
United 
Republic of 
Tanzania Yes 
Yes - poor, 
elderly, 
maternal, 
children, TB, 
leprosy, 
immunisation, 
HIV Somewhat 0-9% Common but low Yes 34 24 35 7
Recent 
experiments 
with community 
and social 
insurance and 
exemptions 1 
Zambia Yes 
Yes - poor, 
elderly, 
orphans, 
maternal, 
children, TB, 
immunisation, 
HIV, all 
patients in 
rural areas 
Somewhat/ 
very 0-9% 
Rare/sometimes/common 
but low Yes 38 10 37 15
User fees were 
removed from 
all health 
services in 
health centres 
and district 
hospitals in 
rural districts in 
April 2006 
(54/72 districts); 
policy extended 3 
 
 Sources of health financing (overall, public and private sectors) 
Country 
Official user 
fees? Exemptions 
Are 
exemptions 
effective? 
% of 
public 
revenues 
raised 
from 
user fees Informal charges 
Malaria 
diagnostics 
charged in 
public 
facilities? 
Out of 
Pocket 
Public 
(domestic) 
Aid New policies Private  
(risk pooled) on user fees N. of 
recently? informants 
to cover 
facilities in peri-
urban areas in 
2007 
Zimbabwe Yes           24 34 19 23   Documents 
ASIA 
Afghanistan Yes 
Poor, TB, 
immunisation Somewhat 0-9% Common and high No  70 7 20 2
Experimenting 
with free care in 
some areas 3 
Bangladesh Yes, but low  
Yes, for 
essential 
service 
package 
services 
Effective for 
official, not 
unofficial 0-9% Common and high No 56 22 15 7
Some demand-
side 
approaches for 
deliveries, e.g. 
vouchers 
External 
expert  
India Yes 
Yes - poor, 
elderly, ex-
servicemen, 
maternal, civil 
servants, TB, 
HIV, leprosy, 
immunisation, 
malaria 
(varies by 
state but 
anything with 
a National 
Programme is 
exempted) Somewhat/very 0-9% 
Varies by state 
(sometimes; common but 
low; common and high) No 76 19 1 5
Free national 
delivery 
programme and 
other nationally 
supported 
priority services 9 
Indonesia Yes 
Yes - special 
insurance for 
poor; 
immunisation 
Reasonably 
effective for 
poor but still 
informal 
barriers 1.20% Common but low Unclear 33 48 2 17
Askeskin 
insurance for 
poor is main 
vehicle for 
reducing user 
fee burden 
External 
expert  
Myanmar 
Disagreement 
- yes and no 
Yes - but not 
sure of 
categories Somewhat 10-19% Rare/Common and high Unclear 83 3 14 0  2 
Nepal Yes 
Free care for 
basic services 
No good 
evidence on 0-9% Sometimes but limited Not sure  59 15 16 10
Moving away 
from user fees 
External 
expert  
 
  
Sources of health financing (overall, public and private sectors) 
Country 
Official user 
fees? Exemptions 
Are 
exemptions 
effective? 
% of 
public 
revenues 
raised 
from 
user fees Informal charges 
Malaria 
diagnostics 
charged in 
public 
facilities? 
Out of 
Pocket 
Public 
(domestic) 
Aid Private  
(risk pooled) 
New policies 
on user fees 
recently? 
N. of 
informants 
introduced 
incrementally 
2006-9, 
including for 
deliveries 
this yet under new 
interim 
Constitution 
Pakistan Yes 
Yes - but not 
disagreement 
on categories 
Not at 
all/somewhat 0-9% Rare/Common and high No 82 13 3 2   2 
Timor-Leste No N/a N/A N/a 
Rare/sometimes (no 
surveys on this) No 4 44 45 7  2 
Cambodia Yes 
Yes - poor, 
orphans, TB, 
leprosy, 
immunisation, 
malaria, HIV Somewhat 10-19% Common and high No  62 4 22 12
Experimenting 
with health 
equity funds to 
increase access 
for poor 1 
China Yes 
Yes - TB and 
other 
categories Somewhat 
30 - 
50%+ Common but low/high   54 42 0 4
Extending rural 
health 
insurance but 
financial 
protection 
shallow 
External 
expert  
Viet Nam Yes 
Yes – TB, 
under-6s, and 
other 
categories Somewhat 20-49% Common but low/high   61 30 2 7
Trying to extend 
voluntary 
insurance 
External 
expert  
 
Note: rows highlighted with a darker border indicate DFID PSA countries (at the time of the research).  
Table 3. Overview of recent user fee policy changes 
 
Country Recent user fee reforms 
Benin Free caesarean policy introduced in 2009 
Burkina Faso Experimenting with free or highly subsidised delivery services since 2006 
Burundi Free care for pregnant women and under-fives since 2006 
Cameroon 
Some trials of demand-side subsidies, e.g. vouchers for deliveries, but not national 
in scale 
Congo Free malaria treatment for children and pregnant women since 2008 
DR Congo Some free basic care provided by NGOs, but limited coverage 
Ghana 
In new Social Health Insurance, pregnant women get free cards since 2008; also 
some indigents; elderly; children of members 
Kenya 
Experimentation with different systems of exemption, subsidy, risk pooling and 
insurance in recent years; deliveries exempt since 2007 
Lesotho Removal of fees for OPD in 2008 and some streamlining of other fees 
Liberia User fees suspended for basic package of health care since 2006 
Madagascar 
User fees lifted on emergency post-conflict basis, then reintroduced. Free deliveries 
since 2008 
Mali Free caesareans since 2005 
Niger Free caesareans (2006) and care of under-fives (2007) 
Rwanda 
Addressed via extension of CHI and subsidies for membership, as well as supply 
side policies 
Senegal Recent introduction of exemptions for delivery care (2006) and elderly 
Sierra Leone Free care for mothers and under-fives in April 2010 
South Africa Free public PHC since 1990s 
Sudan 
Free care for under-fivess and caesareans introduced in north in 2008; South 
recently removed user fees 
Uganda Free care in public sector since 2001 
Tanzania Recent experiments with community and social insurance and exemptions 
Zambia 
User fees were removed from all health services in health centres and district 
hospitals in rural districts in April 2006 (54/72 districts); policy was extended to 
cover facilities in peri-urban areas in 2007 
Afghanistan Experimenting with free care in some areas 
Bangladesh Some demand-side approaches for deliveries, e.g. vouchers 
India Free national delivery programme and other nationally supported priority services 
Indonesia Askeskin insurance for poor is main vehicle for reducing user fee burden 
Nepal Moving away from user fees under new interim Constitution 
Cambodia Experimenting with health equity funds to increase access for poor 
China Extending rural health insurance but financial protection shallow 
Viet Nam Trying to extend voluntary insurance for the rural poor 
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